AIM ImmunoTech Inc. (AIM) Social Stream
AIM ImmunoTech Inc (AIM) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AIM ImmunoTech Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued June 25, 2021
AIM Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- AIM ImmunoTech Inc's number of analysts covering the stock is greater than just about none of of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, AIM ImmunoTech Inc's variance in analysts' estimates is lower than nearly 100% of them.
- AIM ImmunoTech Inc's average analyst price target is greater than 5.44% of Pharmaceutical Products stocks.
- In the context of stocks in the small market cap category, AIM ImmunoTech Inc's upside potential (average analyst target price relative to current price) is greater than 82.64% of them.
Make investment decisions regarding AIM using the data that counts. Try POWR Ratings for free.